First, due to competing events for NI, the association between risk factors of NI as measured using hazard rates may not coincide with the association using cumulative probability (risk).
Fragility curve is developed based on the probabilistic hazard level, cumulative probability function and classification damage-states.
Kaplan-Meier curves and Cox proportional hazard regression models were used to determine cumulative probability of time-to-death and adjusted hazard ratios.
Kaplan Meier analysis was used to assess the cumulative probability of viral rebound and Cox proportional hazards models to calculate crude and adjusted hazard ratios (aHRs).
It was found that the amplitude of the fMRI signal in the SMA after the cue presentation depended on the wait time, resembling the cumulative hazard rate (i.e., the cumulative probability of cue presentation given it has not already been presented).
This difference achieved statistical significance in the first year and in the second year at p < 0.05.> -wrap-foot> Estimates of yearly probability for HIV rebound determined by computing Hazard Rate via the Life Table method and cumulative probability by Kaplan Meier (SAS 9.3, Cary, NC).
For 119 patients in both CD4 strata who achieved 5.7 years of virologic suppression, none had viral rebound at a median of 10 months of follow-up.> -wrap-foot> Estimates of yearly probability for HIV rebound determined by computing Hazard Rate via the Life Table method and cumulative probability by Kaplan Meier analysis (SAS 9.3, Cary, NC).
The cumulative probability of viral rebound (HIV-RNA >200 copies/ml) was assessed by Kaplan Meier analysis; adjusted hazard ratios (aHRs) for the 0 3 and 3 12 months postdelivery (cases)/pseudo-delivery (controls) were calculated in Cox proportional hazards models.
Similarly, the crude cumulative probability of recurrences while accounting for the dependence of the cumulative probability function on the hazards of other competing event (i.e., mortality) was calculated.
The crude cumulative probability of mortality while accounting for the dependence of the cumulative probability function on the hazards of other competing event (i.e., disease recurrence) was calculated.
